Effects of Autogenic Inhibition Versus Reciprocal Inhibition in Individuals With Lower Cross Syndrome

ConditionLower Cross Syndrome

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age25-50

SponsorFoundation University Islamabad

About this trial

This study examines the effects of autogenic inhibition (PFS) versus reciprocal inhibition in individuals with lower cross syndrome

Eligibility criteria

Qualifiers

Both Males and Females will be included in our study Age 25-50 years Four positive screening tests (Thomas Test, Abdominal Strength Test, Glutues Maximus Test, Ely's Test) chronic Pain in lower Back Region (>3 on VAS) lasting for more than 2 months

Disqualifiers

Osteoporosis Congenital Hip Dysplasia History of Fracture History of Inflammatory Arthritis Pregnancy

Trial design

Treatments tested in this trial

Autogenic Inhibition (PFS) Group A
Reciprocal Inhibition Group B

Treatment groups

72 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Foundation University Islamabad

Lead sponsor

Source ClinicalTrials.gov